Australia markets close in 1 hour 42 minutes

NeuroBo Pharmaceuticals, Inc. (NRBO)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
3.0600-0.0400 (-1.29%)
At close: 04:00PM EDT
3.0600 0.00 (0.00%)
After hours: 04:21PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-13,869
-12,470
-13,967
-15,284
-29,678
Depreciation & amortisation
31
6
20
48
46
Stock-based compensation
824
222
854
662
699
Change in working capital
121
4,397
-1,168
-584
809
Accounts payable
598
113
-202
-1,162
1,123
Other working capital
-12,804
-10,849
-11,712
-15,137
-10,768
Other non-cash items
14
1
8,218
24
17,360
Net cash provided by operating activities
-12,804
-10,799
-11,712
-15,134
-10,764
Cash flows from investing activities
Investments in property, plant and equipment
-50
-50
-
-3
-4
Other investing activities
-
-
-
-583
73
Net cash used for investing activities
-575
-50
8
-586
69
Cash flows from financing activities
Common stock issued
14,000
-
32,250
24,000
7,500
Other financing activities
-1,291
-80
-3,569
-2,089
-695
Net cash used provided by (used for) financing activities
12,752
-80
28,681
22,026
6,858
Net change in cash
-627
-10,929
16,977
6,306
-3,837
Cash at beginning of period
6,984
33,364
16,387
10,089
13,923
Cash at end of period
6,357
22,435
33,364
16,387
10,089
Free cash flow
Operating cash flow
-12,804
-10,799
-11,712
-15,134
-10,764
Capital expenditure
-50
-50
-
-3
-4
Free cash flow
-12,804
-10,849
-11,712
-15,137
-10,768